Skip to main content
Log in

Azelnidipine Inhibits H2O2-Induced Cell Death in Neonatal Rat Cardiomyocytes

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Purpose

Oxidative stress plays an important role in the pathogenesis of cardiovascular diseases. Azelnidipine is a novel dihydropyridine calcium channel blocker. Several studies have demonstrated that some dihydropyridine calcium channel blockers have antioxidant effects. We evaluated the antioxidant effects of azelnidipine compared to another dihyropyridine calcium channel blocker, nifedipine, in neonatal rat cardiomyocytes.

Materials and methods

We examined effects of azelnidipine and nifedipine on the H2O2-induced mitogen-activated protein kinase (MAPK) activity and cell death in neonatal rat cardiomyocytes.

Results

Extracellular signal-regulated protein kinases (ERK), p38 MAPK and c-Jun NH2-terminal kinases (JNK) were activated by H2O2 stimulation. Azelnidipine and nifedipine did not affect the H2O2-induced activation of ERK and p38 MAPK. In contrast, azelnidipine, but not nifedipine, inhibited the H2O2-induced JNK activation. The numbers of viable cell were significantly decreased by H2O2 treatments (65.8 ± 4.11% of control, P < 0.0001). Azelnidipine, but not nifedipine, inhibited the H2O2-induced cell death (azelnidipine: 76.0 ± 4.66% of control, P < 0.05; nifedipine: 70.7 ± 4.01% of control, P = 0.32).

Conclusion

Azelnidipine inhibited the H2O2-induced JNK activation and cardiac cell death. Azelnidipine may have cardioprotective effects against oxidative stress.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, Colucci WS. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 2002;34:379–88.

    Article  PubMed  CAS  Google Scholar 

  2. Baines CP, Molkentin JD. STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol 2005;38:47–62.

    Article  PubMed  CAS  Google Scholar 

  3. Kwon SH, Pimentel DR, Remondino A, Sawyer DB, Colucci WS. H(2)O(2) regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. J Mol Cell Cardiol 2003;35:615–21.

    Article  PubMed  CAS  Google Scholar 

  4. Oizumi K, Nishino H, Koike H, Sada T, Miyamoto M, Kimura T. Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker. Jpn J Pharmacol 1989;51:57–64.

    Article  PubMed  CAS  Google Scholar 

  5. Yamagishi S, Inagaki Y, Nakamura K, Imaizumi T. Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties. J Cardiovasc Pharmacol 2004;43:724–30.

    Article  PubMed  CAS  Google Scholar 

  6. Shinomiya K, Mizushige K, Fukunaga M, Masugata H, Ohmori K, Kohno M, Senda S. Antioxidant effect of a new calcium antagonist, azelnidipine, in cultured human arterial endothelial cells. J Int Med Res 2004;32:170–75.

    PubMed  CAS  Google Scholar 

  7. Takahashi H, Takeishi Y, Seidler T, Arimoto T, Akiyama H, Hozumi Y, Koyama Y, et al. Adenovirus-mediated overexpression of diacylglycerol kinase-zeta inhibits endothelin-1-induced cardiomyocyte hypertrophy. Circulation 2005;111:1510–6.

    Article  PubMed  CAS  Google Scholar 

  8. Nitobe J, Yamaguchi S, Okuyama M, Nozaki N, Sata M, Miyamoto T, Takeishi Y, et al. Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes. Cardiovasc Res 2003;57:119–28.

    Article  PubMed  CAS  Google Scholar 

  9. Mak IT, Weglicki WB. Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation. Circ Res 1990;66:1449–52.

    PubMed  CAS  Google Scholar 

  10. Mak IT, Boehme P, Weglicki WB. Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells. Correlation of protection with preservation of glutathione levels. Circ Res 1992;70:1099–103.

    PubMed  CAS  Google Scholar 

  11. Mason RP, Leeds PR, Jacob RF, Hough CJ, Zhang KG, Mason PE, Chuang DM. Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells. J Neurochem 1999;72:1448–56.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank Sankyo Pharmaceutical Co., Tokyo, Japan for providing azelnidipine.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasuchika Takeishi.

Additional information

This study was supported in part by a grant-in-aid for Scientific Research (No. 17590702) from the Ministry of Education, Science, Sports and Culture, Japan, a grant-in-aid from the twenty-first century center of excellence (COE) program of the Japan Society for the Promotion of Science, and grants from Takeda Science Foundation and Fukuda Foundation for Medical Technology.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koyama, Y., Takeishi, Y., Takahashi, H. et al. Azelnidipine Inhibits H2O2-Induced Cell Death in Neonatal Rat Cardiomyocytes. Cardiovasc Drugs Ther 21, 69–72 (2007). https://doi.org/10.1007/s10557-007-6008-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10557-007-6008-4

Key words

Navigation